Dr Daniel D’Hotman
MBBS (HONS), BMEDSC (HONS)
Daniel D’Hotman is an Australian Rhodes Scholar and medical doctor. He is currently completing a DPhil (PhD) on the ethics and politics of using AI for suicide prevention at the University of Oxford. Daniel is a co-author of Medicinal Use of Psilocybin: Reducing Restrictions on Treatment, a report commissioned by the Adam Smith Institute.
Daniel recently completed a Policy Fellowship at the Department of Prime Minister and Cabinet in Canberra, examining the potential to use digital technologies for mental illness. He has published a variety of academic papers, with one of these articles selected amongst the ‘Best in Philosophy’ collection for 2019 by Oxford University Press.
Dr Jesse Schnall
Jesse Schnall is a junior medical doctor from Melbourne and a co-author of Medicinal Use of Psilocybin: Reducing Restrictions on Treatment, a report commissioned by the Adam Smith Institute. He was a visiting philosophy student at the University of Oxford and an intern at the World Health Organization office at the United Nations. He believes that good healthcare should be accessible to everyone, and that good health policy should be based on evidence and compassion.
BSC, BMED (2021)
Finnebar is a medical student with a background in Statistics and Molecular Biology. After completing his BSc, he worked in the banking sector but discovered he missed science and its capacity to change lives. Consequently, evidence-driven mental health innovation and health equity have become his primary focus. Recently he completed time at Broadmoor Hospital in association with Imperial College London and the West London NHS Trust to study innovation in Forensic Mental Health. Previously, he has received a New Columbo Grant for travel to study equity in healthcare access across China and India. His time abroad has both challenged and informed his thinking on what is necessary to improve health outcomes across cultural boundaries in multicultural societies.